Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Myeloid 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Colorectal Neoplasms 50Carcinoma, Non-Small-Cell Lung 26Squamous Cell Carcinoma of Head and Neck 25Head and Neck Neoplasms 12Neoplasm Metastasis 11Neoplasms 10Colonic Neoplasms 10Rectal Neoplasms 9Pancreatic Neoplasms 9Lung Neoplasms 9Mouth Neoplasms 6Carcinoma, Squamous Cell 6Carcinoma 6Laryngeal Neoplasms 5Hypopharyngeal Neoplasms 5Oropharyngeal Neoplasms 4Thyroid Neoplasms 3Solid Tumors 3Ovarian Neoplasms 3Gastrointestinal Neoplasms 3Endometrial Neoplasms 3Carcinoma, Pancreatic Ductal 3Breast Neoplasms 3Sarcoma 2Recurrence 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Laryngeal Diseases 2mCRC 1Urologic Neoplasms 1Triple Negative Breast Neoplasms 1

Interventions

Radiosurgery 25Temozolomide 16Magnetic Resonance Spectroscopy 14pembrolizumab 11Bevacizumab 11Nivolumab 10Ipilimumab 8Specimen Handling 6Memantine 6abemaciclib 5Radiotherapy 5Mental Status and Dementia Tests 5Blood Specimen Collection 5Radiation 4entrectinib 3Surveys and Questionnaires 3Sodium Chloride 3Saline Solution 3Receptors, Interleukin-8B 3Proton Therapy 3Lomustine 3trastuzumab deruxtecan 2trametinib 2pertuzumab 2osimertinib 2lenvatinib 2fluciclovine F-18 2contrast agent BR1 2atezolizumab 2X-Rays 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Cetuximab × 90 days × Clear all
NCT05786924 2026-04-21

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Servier

Phase 1/2 Recruiting
554 enrolled
CNSGastrointestinalHead & NeckMyeloidThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡